CoChat

Low Intracellular Iron Increases the Stability of Matriptase-2

Open access
Zhao, Ningning, Nizzi, Christopher P., Anderson, Sheila A., Wang, Jiaohong, Ueno, Akiko, Tsukamoto, Hidekazu, Eisenstein, Richard S., Enns, Caroline A., Zhang, An-Sheng · 2015 · Journal of Biological Chemistry
Cited by 51

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Matriptase-2 (MT2) is a type II transmembrane serine protease that is predominantly expressed in hepatocytes. It suppresses the expression of hepatic hepcidin, an iron regulatory hormone, by cleaving membrane hemojuvelin into an inactive form. Hemojuvelin is a bone morphogenetic protein (BMP) co-receptor. Here, we report that MT2 is up-regulated under iron deprivation. In HepG2 cells stably expressing the coding sequence of the MT2 gene, TMPRSS6, incubation with apo-transferrin or the membrane-impermeable iron chelator, deferoxamine mesylate salt, was able to increase MT2 levels. This increase did not result from the inhibition of MT2 shedding from the cells. Rather, studies using a membrane-permeable iron chelator, salicylaldehyde isonicotinoyl hydrazone, revealed that depletion of cellular iron was able to decrease the degradation of MT2 independently of internalization. We found that lack of the putative endocytosis motif in its cytoplasmic domain largely abolished the sensitivity of MT2 to iron depletion. Neither acute nor chronic iron deficiency was able to alter the association of Tmprss6 mRNA with polyribosomes in the liver of rats indicating a lack of translational regulation by low iron levels. Studies in mice showed that Tmprss6 mRNA was not regulated by iron nor the BMP-mediated signaling with no evident correlation with either Bmp6 mRNA or Id1 mRNA, a target of BMP signaling. These results suggest that regulation of MT2 occurs at the level of protein degradation rather than by changes in the rate of internalization and translational or transcriptional mechanisms and that the cytoplasmic domain of MT2 is necessary for its regulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m114.611913

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. De Domenico, 2008, The hepcidin-binding site on ferroportin is evolutionarily conserved, Cell Metab, 8, 146, 10.1016/j.cmet.2008.07.002 · DOI · Paper page
  2. Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742 · DOI · Paper page
  3. Huang, 2005, A mouse model of juvenile hemochromatosis, J. Clin. Invest, 115, 2187, 10.1172/JCI25049 · DOI · Paper page
  4. Niederkofler, 2005, Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload, J. Clin. Invest, 115, 2180, 10.1172/JCI25683 · DOI · Paper page
  5. Steinbicker, 2011, Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice, Blood, 118, 4224, 10.1182/blood-2011-03-339952 · DOI · Paper page
  6. Lee, 2010, Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis, Blood, 115, 3136, 10.1182/blood-2009-11-251199 · DOI · Paper page
  7. Babitt, 2011, The molecular pathogenesis of hereditary hemochromatosis, Semin. Liver Dis, 31, 280, 10.1055/s-0031-1286059 · DOI · Paper page
  8. Folgueras, 2008, The membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis, Blood, 112, 2539, 10.1182/blood-2008-04-149773 · DOI · Paper page
  9. Velasco, 2002, Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins, J. Biol. Chem, 277, 37637, 10.1074/jbc.M203007200 · DOI · Paper page
  10. Zhang, 2011, Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matripatase-2 protein, Blood, 117, 1687, 10.1182/blood-2010-06-287292 · DOI · Paper page
  11. Ramsay, 2009, Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis, Haematologica, 94, 840, 10.3324/haematol.2008.001867 · DOI
  12. Béliveau, 2011, Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality, J. Biol. Chem, 286, 29035, 10.1074/jbc.M111.223461 · DOI
  13. Zhang, 2005, Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells, J. Biol. Chem, 280, 33885, 10.1074/jbc.M506207200 · DOI · Paper page
  14. Zhang, 2009, Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression, J. Biol. Chem, 284, 22580, 10.1074/jbc.M109.027318 · DOI · Paper page
  15. Chen, 2011, Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis, Blood, 117, 6319, 10.1182/blood-2010-12-327957 · DOI · Paper page
  16. Finberg, 2010, Downregulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis, Blood, 115, 3817, 10.1182/blood-2009-05-224808 · DOI · Paper page
  17. Meynard, 2011, Regulation of TMPRSS6 by BMP6 and iron in human cells and mice, Blood, 118, 747, 10.1182/blood-2011-04-348698 · DOI · Paper page
  18. Enns, 2012, Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage, J. Biol. Chem, 287, 35104, 10.1074/jbc.M112.363937 · DOI · Paper page
  19. Zhao, 2010, ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin, J. Biol. Chem, 285, 32141, 10.1074/jbc.M110.143248 · DOI · Paper page
  20. Uhles, 2007, Selective gene activation by spatial segregation of insulin receptor B signaling, FASEB J, 21, 1609, 10.1096/fj.06-7589com · DOI
  21. Zhang, 2007, Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin, J. Biol. Chem, 282, 12547, 10.1074/jbc.M608788200 · DOI · Paper page
  22. Anthony, 2001, Oral administration of leucine stimulates ribosomal protein mRNA translation but not global rates of protein synthesis in the liver of rats, J. Nutr, 131, 1171, 10.1093/jn/131.4.1171 · DOI
  23. Zhang, 2010, The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo, J. Biol. Chem, 285, 16416, 10.1074/jbc.M110.109488 · DOI · Paper page
  24. Maxson, 2010, Matriptase-2- and proprotein convertase-cleaved forms of hemojuvelin have different roles in the down-regulation of hepcidin expression, J. Biol. Chem, 285, 39021, 10.1074/jbc.M110.183160 · DOI · Paper page
  25. Young, 1997, Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells, FEBS Lett, 411, 93, 10.1016/S0014-5793(97)00478-X · DOI · Paper page
  26. Baker, 1985, Transferrin and iron release from rat hepatocytes in culture, Am. J. Physiol, 248, G93
  27. Stirnberg, 2010, The proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface, Biochem. J, 430, 87, 10.1042/BJ20091565 · DOI
  28. Zhao, 2014, An iron-regulated and glycosylation-dependent proteasomal degradation pathway for the plasma membrane metal transporter ZIP14, Proc. Natl. Acad. Sci. U.S.A, 111, 9175, 10.1073/pnas.1405355111 · DOI · Paper page
  29. Chen, 1998, Dietary iron intake rapidly influences iron regulatory proteins, ferritin subunits and mitochondrial aconitase in rat liver, J. Nutr, 128, 525, 10.1093/jn/128.3.525 · DOI
  30. Chen, 1997, Dietary iron intake modulates the activity of iron regulatory proteins and the abundance of ferritin and mitochondrial aconitase in rat liver, J. Nutr, 127, 238, 10.1093/jn/127.2.238 · DOI
  31. Schalinske, 1996, Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells, J. Biol. Chem, 271, 7168, 10.1074/jbc.271.12.7168 · DOI · Paper page
  32. Zhao, 2013, Iron regulation by hepcidin, J. Clin. Invest, 123, 2337, 10.1172/JCI67225 · DOI · Paper page
  33. Nai, 2010, Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient mice, Blood, 116, 851, 10.1182/blood-2010-04-278655 · DOI · Paper page
  34. Maurer, 2013, Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2, Biochem. J, 450, 583, 10.1042/BJ20121518 · DOI
  35. Zhao, 2013, Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1, J. Biol. Chem, 288, 11155, 10.1074/jbc.M113.454611 · doi:10.1074/jbc.m113.454611
  36. Szabo, 2009, Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice, Development, 136, 2653, 10.1242/dev.038430 · DOI
  37. Larsen, 2013, Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase, Exp. Cell Res, 319, 918, 10.1016/j.yexcr.2013.01.008 · DOI
  38. Parr, 2010, Hepatocyte growth factor activation inhibitors- therapeutic potential in cancer, Anticancer Agents Med. Chem, 10, 47, 10.2174/1871520611009010047 · DOI
  39. Gkouvatsos, 2011, Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin, Hepatology, 54, 1800, 10.1002/hep.24547 · DOI · Paper page

Cited by

See all 51

Metadata

Authors
Zhao, N., Nizzi, C. P., Anderson, S. A., Wang, J., Ueno, A., Tsukamoto, H., Eisenstein, R. S., Enns, C. A., & Zhang, A.-S.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2015-02
Volume
290
Issue
7
Pages
4432-4446
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2044404591
Cited by
51
References
14
FWCI
3.67
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
National Institutes of Health (DK080765, DK102791, DK054488, K99DK104066, DK066600, P50AA11199, R24AA12885)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.